Skip to main content
Caplight Logo









Rapalogix Health

Rapalogix Health

Private
Carlsbad, CaliforniaHealthcare & Life Scienceshttps://rapalogix.com/

Last Round

Series A

Jun 23, 2026

Total Funding Raised

$33.5M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Rapalogix Health is a biotechnology company that develops a pipeline of prescription therapeutics and professional skincare products based on longevity science to address skin aging at the cellular level.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B2C

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

physician-dispensed skincaremedical-grade skincarecosmeceuticalsdermatologylongevity scienceanti-aging skincareaesthetic medicinetopical moleculesdrug discoverybiotechnologyB2B2CAI-augmentedAI skin analysismolecular diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rapalogix Health Comparables

Compare Rapalogix Health with similar companies based on industry and business-model similarity.

Rapalogix Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cambrian Bio
32%

Rapalogix Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 23, 2026

Key People

Founding team and executive leadership

Rahul Mehta

Co-Founder and CEO

Founding Team

Tom Christenson

Fractional CFO

Executive Team

Rapalogix Health Investors

Notable investors and investment history

Rapalogix Health investors
InvestorRounds
GordonMD Global InvestmentsSeries A
Woodline PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 28, 2026

    Grew 65% QoQ, from 17 to 28 employees.

  • Aug 21, 2026

    Monthly visitors grew 68% MoM, reaching 3.5K.

Rapalogix Health Filings

Explore SEC and related filing metadata, where available.

Rapalogix Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Rapalogix Health's valuation, stock price, and market status.

Is Rapalogix Health a public or private company?

Rapalogix Health is a private company.

What is the current stock price of Rapalogix Health?

Rapalogix Health is a private company with no public stock price. No recent secondary market data is available.

How much is Rapalogix Health worth (valuation)?

Valuation information for Rapalogix Health is not publicly available.

Can I buy Rapalogix Health stock?

Rapalogix Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Rapalogix Health's last funding round?

Rapalogix Health's most recent funding round was Series A on June 23, 2026.

Who are the main investors in Rapalogix Health?

Key investors in Rapalogix Health include GordonMD Global Investments, Woodline Partners.

Will Rapalogix Health IPO soon?

No public IPO plans have been announced for Rapalogix Health.

How can I track Rapalogix Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rapalogix Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCarlsbad, California
Employee Range24
Year Founded2023
Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?